Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC.

Research output: Contribution to journal › Article › Academic › peer-review

Cite this

@article{1c7e205d31814bef80b6c4d9a74031ad,

title = "Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC.",

author = "R.H. Medema and C.C. Lin and J.C. Yang",

year = "2011",

language = "English",

volume = "17",

pages = "6459--6466",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "20",

}